Air pollution is a heterogeneous mixture of gases and solid particles in the air, each component having its own potential effect on the human body. There is increasing evidence that air pollution may cause systemic inflammation and elevated blood pressure ([@r5]; [@r7]). Several studies have explored the association between air pollution and negative birth outcomes ([@r4]; [@r17]; [@r18]; [@r29]; [@r41]), but few studies have studied the effect of air pollution on pregnancy complications. Preeclampsia and other pregnancy complications have been identified as priority research areas relating to air pollution and reproductive effects ([@r44]). Adverse maternal outcomes are of relevance per se, but may also provide insights into the mechanisms behind negative birth outcomes.

Previous studies have reported associations between air pollution and type 2 diabetes, and it has been proposed that systemic inflammation may be the underlying biological mechanism ([@r6]; [@r12]; [@r21]). Pregnancy is a condition with an increased susceptibility to diabetogenesis ([@r9]); consequently, pregnant women might be a group susceptible to potential air pollution effects on the incidence of diabetes. To our knowledge there has been only one previous study of air pollution and gestational diabetes, which reported no association ([@r38]).

Preeclampsia causes maternal mortality, morbidity, perinatal death, intrauterine growth restriction, and preterm birth ([@r26]). Several recent studies have reported positive associations between preeclampsia and air pollutants including nitrogen oxides (NO~x~), nitrogen monoxide (NO), nitrogen dioxide (NO~2~), carbon monoxide (CO), ozone (O~3~), particulate matter \< 2.5 μm in aerodynamic diameter (PM~2.5~), and particulate matter \< 10 μm in aerodynamic diameter (PM~10~) ([@r14]; [@r45], [@r46]), but others have reported no association with PM~2.5~ or CO ([@r24]) and inconclusive findings for PM~10~ and NO~2~ ([@r37]). Two studies have reported positive associations between gestational hypertension (a risk factor and early symptom of preeclampsia) and air pollutants \[PM~10~ and PM~2.5~ ([@r39]) and NO~2~ and PM~10~ ([@r37])\].

Etiologic mechanisms leading to gestational diabetes and preeclampsia are uncertain, but systemic inflammation may be a contributing factor ([@r26]; [@r40]). Both experimental and observational evidence indicates that exposure to air pollution, particularly ultrafine particles, induces oxidative stress and consequently inflammation (reviewed by [@r34]).

In previous studies, levels of NO~x~ have been shown to correspond well with levels of combustion-related particulate matter \< 1 μm in aerodynamic diameter (PM~1~), or even for combustion-related ultrafine particulate matter (\< 0.1 μm; PM~0.1~) ([@r3]; [@r11]; [@r19]). Ambient NO~2~ concentrations in Scania, Sweden, the site of the present study, are generally well below current World Health Organization (WHO) air quality guidelines (NO~2~ annual average \< 40 µg/m^3^; [@r43]). Exposure data of high spatial resolution are readily available from a recent cohort study of \> 80,000 children born in Scania during 1999--2005; this study explored the relationship between maternal exposure to air pollution and birth outcomes ([@r18]). The aim of the present study was to assess maternal morbidity in this cohort. The Swedish Medical Birth Registry (National Board for Health and Welfare, Stockholm, Sweden) contains information from maternal health care records on relevant confounders, and almost all pregnant women (98--99%) attend the tax-subsidized antenatal health care system ([@r30]), where a screening program for gestational diabetes has been operating since 1995. Thus, information on maternal outcomes and exposures in the total population was available, which is unique.

Materials and Methods
=====================

*Study area*. The study was carried out in Scania, a county in southern Sweden. Sweden's third largest city (Malmö; \~ 260,000 inhabitants) is located in Scania, and the county is densely populated compared with the rest of the country, with approximately 1.2 million people living within 11,000 km^2^. Because of its proximity to the European continent and the Danish capital, Copenhagen, a great deal of cargo is transported to, from, and through this region by road, rail, and water, resulting in high levels of emissions relative to other parts of Sweden. Although the air pollution levels vary considerably within the county, they are generally below the present WHO air quality guidelines for NO~2~, PM~10~, and O~3~ ([@r28]; [@r43]).

*Study population*. The Swedish Medical Birth Registry includes almost all (98--99%) infants born in Sweden ([@r30]). The present study included 81,110 women who had singleton deliveries during 1999--2005. The study population has previously been described in detail ([@r18]). This study was approved by the Lund University Ethical Committee. No formal informed consent was required, but the study was advertised in the local newspaper and women could request not to be included in it, though none did.

*Outcome measurements*. Gestational diabetes. In Scania, an oral glucose tolerance test is routinely performed during pregnancy week 28 to screen for gestational diabetes. The test is offered to all pregnant women and has a participation rate of approximately 93% ([@r2]). Women with a first-degree family history of diabetes, or a history of gestational diabetes in a previous pregnancy, are additionally screened during week 12. Gestational diabetes is diagnosed based on plasma glucose \> 10 mmol/L 2 hr after oral administration of 75 g of glucose. If results indicate impaired glucose tolerance (plasma glucose 8.6--9.9 mmol/L), the test is repeated within a week ([@r1]). If a diagnosis of gestational diabetes was not indicated in the Swedish Medical Birth Registry, women were presumed not to have gestational diabetes. There were 1,599 cases of gestational diabetes registered.

Preeclampsia. Blood pressure and proteinuria are routinely measured at each visit to the maternal health care units, and preeclampsia is diagnosed according to the *International Classification of Diseases, 10th Revision* ([@r42]; codes P07.0--P07.3) based on systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg (measured twice with at least 6 hr between) and proteinuria \> 0.3 g/day after 20 weeks of gestation. The diagnostic criterion for severe preeclampsia is blood pressure ≥ 160/110 mmHg or proteinuria ≥ 5 g/day. Altogether, there were 2,370 cases of preeclampsia, including 1,799 classified as mild and 571 as severe. Women without a diagnosis of preeclampsia in the Swedish Medical Birth Registry were presumed not to have preeclampsia.

*Exposure assessments*. Modeled NO~x~ exposure. We acquired information on NO~x~ in Scania from an emission database (EDB) with information on approximately 24,000 sources ([@r32]) including line sources (road traffic, shipping, and railroads), point sources (industries and larger energy and heat producers), and area sources (aviation, small-scale heating, and construction machinery). Emissions from eastern Denmark, which are quite high in Scania due to prevailing westerly winds, were also included ([@r13]). For dispersion calculations, the EDB was combined with AERMOD, a modified Gaussian flat two-dimensional dispersion model ([@r35]) that incorporates meteorological data ([@r32]). Modeled concentrations with a spatial resolution of 100 × 100 m were highly correlated with façade concentrations measured over 1-week periods (Spearman's correlation coefficient = 0.8, *n* = 142) ([@r33]). To account for long-range transboundary air pollution (in addition to the emissions from Eastern Denmark) we added a background level of 2.5 µg/m^3^ to the model, which corresponds to the yearly mean value obtained from a local remote background monitor station.

For the present study, concentrations of NO~x~ were modeled as hourly means with a spatial resolution of 500 × 500 m. Hourly means were aggregated into monthly and trimester means for each pregnancy (gestation months 1--3, 4--6, and 7--delivery). Different spatial resolutions have been studied, and a resolution of 500 × 500 m was considered optimal when calculating monthly means in this study area, because temporal aggregation allowed lower spatial resolution without significant loss of detail ([@r31]). Concentrations were calculated at the women's geocoded residence.

Because of migration in and out of the county, NO~x~ exposures could not be estimated for the first, second, and third trimesters for 5,201, 4,756, and 4,585 women, respectively. Women were excluded from trimester-specific analyses when trimester-specific data were missing, but were included in all other analyses with available exposure data.

The average level of modeled NO~x~ exposure decreased from 18.2 µg/m^3^ in 1999 to 13.3 µg/m^3^ in 2005, with an average of 16.4 µg/m^3^ over the entire study period. NO~x~ was categorized into quartiles based on the distribution of individual exposures during the first trimester \[reference, 2.5--8.9 µg/m^3^ (mean = 6.8 µg/m^3^); 9.0--14.1 µg/m^3^ (mean = 11.4 µg/m^3^); 14.2--22.6 µg/m^3^ (mean = 18.2 µg/m^3^); ≥ 22.7 µg/m^3^ (mean = 29.6 µg/m^3^)\].

*Traffic density*. Road traffic data were obtained from the Swedish National Road Database ([@r36]) and used to calculate the distance between the geocoded location of each mother's residence during the first trimester and the road with the heaviest traffic density (annual 24-hr mean value) within a 200-m radius. Mothers who migrated into Scania after the first trimester were excluded from analyses of traffic density (*n* = 5,536). Traffic density was categorized as no road within 200 m (reference category), road with \< 2 cars/min, road with 2--5 cars/min, road with 6--10 cars/min, or road with \> 10 cars/min. These categories were chosen to correspond with previous studies in this area ([@r15]; [@r18]).

*Covariates*. We adjusted analyses of preeclampsia for major risk factors including prepregnancy body mass index (BMI), smoking habits at first antenatal visit, ethnicity (based on country of birth), parity, type 1 diabetes, gestational diabetes, and maternal age ([@r25]; [@r27], [@r26]), which were available from the Swedish Medical Birth Registry for the women in the study. These factors, except smoking, are also relevant risk factors for gestational diabetes, and were therefore included in models of that outcome as well ([@r9]; [@r25]). These covariates were categorized as shown in [Table 1](#t1){ref-type="table"}, including categories for missing data on pre-pregnancy BMI and smoking. To account for calendar year effects, we also adjusted for year of delivery (1999--2005). To account for multiple pregnancies per woman, we conducted restricted analyses including only first pregnancies.

###### 

Description of study subjects \[*n* (%)\]

  Characteristic             Preeclampsia (n = 2,323)   Gestational diabetes (n = 1,599)   All (n = 81,110)
  -------------------------- -------------------------- ---------------------------------- ------------------
  Maternal age (years)                                                                     
  \< 25                      357 (15.4)                 141 (8.8)                          11,708 (14.4)
  25--30                     745 (32.1)                 409 (25.6)                         26,256 (32.4)
  30--35                     767 (33.0)                 544 (34.0)                         28,401 (35.0)
  ≥ 35                       454 (19.5)                 505 (31.6)                         14,745 (18.2)
  Country of origin                                                                        
  Sweden                     1,877 (84.6)               972 (63.0)                         62,128 (76.6)
  Other Nordic               32 (1.4)                   19 (1.2)                           1,564 (1.9)
  Other Western              22 (1.0)                   17 (1.1)                           1,111 (1.4)
  Eastern Europe             118 (5.3)                  118 (7.6)                          5,576 (6.9)
  Africa Sub Sahara          27 (1.2)                   48 (3.1)                           884 (1.1)
  Middle East/North Africa   95 (4.3)                   270 (17.5)                         5,754 (7.1)
  Asia                       25 (1.1)                   84 (5.4)                           1,858 (2.3)
  South/Central America      23 (1.0)                   16 (1.0)                           738 (0.9)
  Parity                                                                                   
  1                          1,603 (69.0)               674 (42.2)                         38,365 (47.3)
  2                          464 (20.0)                 485 (30.3)                         26,681 (32.9)
  ≥ 3                        255 (11.0)                 440 (27.5)                         15,418 (19.0)
  BMI                                                                                      
  \< 18.5                    37 (1.6)                   23 (1.4)                           2,944 (3.6)
  18.5--24.9                 640 (27.6)                 536 (33.5)                         31,629 (39.0)
  25--29.9                   598 (25.7)                 432 (27.0)                         17,836 (22.0)
  ≥ 30                       477 (20.5)                 375 (23.5)                         7,852 (9.7)
  Missing                    571 (24.6)                 233 (14.6)                         20,849 (25.7)
  Smoking (cigarettes/day)                                                                 
  0                          1,902 (81.9)               1,264 (79.0)                       66,086 (81.5)
  1--9                       128 (5.5)                  113 (7.1)                          6,444 (7.9)
  \> 10                      44 (1.9)                   54 (3.4)                           2,948 (3.6)
  Missing                    249 (10.7)                 168 (10.5)                         5,632 (6.9)
  Diabetes type 1            53 (2.3)                   301 (18.8)                         406 (0.5)
  Chronic hypertension       110 (4.7)                  28 (1.8)                           352 (0.4)
  Changed residency          325 (13.3)                 160 (10.0)                         9,157 (11.3)
  Birth year                                                                               
  1999                       281 (12.1)                 144 (9.0)                          10,593 (13.1)
  2000                       283 (12.2)                 182 (11.4)                         11,018 (13.6)
  2001                       287 (12.4)                 268 (16.8)                         11,107 (13.7)
  2002                       310 (13.3)                 208 (13.0)                         11,720 (14.4)
  2003                       316 (13.6)                 277 (17.3)                         11,473 (14.1)
  2004                       355 (15.3)                 295 (18.4)                         12,449 (15.3)
  2005                       491 (21.1)                 225 (14.1)                         12,750 (15.7)
  Gestational diabetes       119 (5.1)                                                     1,599 (2.0)

No information was available on other risk factors for gestational diabetes---previous gestational diabetes, family history of type 2 diabetes, polycystic ovary syndrome, low own birth weight, and low physical activity.

*Database linkage*. Each resident of Sweden has a unique 10-digit personal identification code that can be linked to the center coordinate of her or his location of residence (updated yearly). A woman could have multiple locations and thus different trimester-specific exposure if she moved residence during pregnancy. However, we lacked information on exact timing of the move, and to account for this we conducted restricted analyses with women who had not moved during pregnancy. Residential coordinates were linked to modeled exposure and traffic data by using a geographical information system, and each assessed individual exposure was subsequently linked to information from the Swedish Medical Birth Registry, with the aid of the personal identification code.

*Statistics*. Gestational diabetes and preeclampsia were examined as dichotomous outcomes in logistic regression models, using IBM SPSS Statistics, version 20 (IBM Inc., Chicago, IL, USA). In addition to analyses of all preeclampsia cases, we conducted separate analyses restricted to mild and severe preeclampsia cases, respectively. Women with type 1 diabetes (*n* = 406) were excluded from analyses of gestational diabetes, and women with chronic hypertension (*n* = 352) were excluded from analyses of preeclampsia, thus avoiding potential misclassification of cases as noncases.

For the gestational diabetes analyses we estimated associations with NO~x~ exposure during the first or second trimester only---before the screening in week 28. Associations with NO~x~ exposure during all three trimesters were estimated for the preeclampsia analyses.

Associations between NO~x~, traffic density and gestational diabetes were estimated for all women without adjustment and with adjustment for maternal age, parity, BMI, calendar year, and country of origin. In addition we estimated crude and adjusted odds ratios (ORs) based on analyses restricted to primiparae, to women who did not move residence during pregnancy, and to women who were born in Nordic countries.

Associations between NO~x~, traffic density, and preeclampsia were estimated for all women without adjustment and with adjustment for maternal age, parity, smoking, BMI, gestational diabetes, type 1 diabetes, country of origin, and calendar year. As for analyses of gestational diabetes, we also ran analyses restricted to primiparae, women who did not move residence during pregnancy, and women born in Nordic countries. In addition, we repeated all analyses after excluding women diagnosed with severe preeclampsia, and after excluding women diagnosed with mild preeclampsia from the analyses.

Because NO~x~ levels vary between urban and nonurban areas, associations may be confounded by unmeasured environmental and socioeconomic risk factors that also differ between urban and non-urban areas. Therefore, we subdivided the cohort into urban women living in the two main cities, Malmö and Helsingborg, and non-urban women (all others) and estimated separate associations between the outcomes and NO~x~ above versus below the average level for each group (21.2 µg/m^3^ for the urban group, and 8.9 µg/m^3^ for the non-urban group). These analyses were restricted to Nordic-born women to reduce potential confounding by other unmeasured factors related to ethnicity. Analyses were performed with fully adjusted models for all outcomes.

Results
=======

*Covariates and potential confounding*. Women in the highest NO~x~ quartile were predominantly primiparae (55% fourth quartile compared with 40% first quartile) and had non-Nordic origin (35% fourth quartile compared with 8% first quartile) \[see Supplemental Material, Table S1 (http://dx.doi.org/10.1289/ehp.1205736)\]. In contrast, \> 90% of women within the lowest quartile were of Swedish origin. There were no differences in smoking between quartiles. There was a higher prevalence of overweight/obese (BMI ≥ 25) in the lowest quartile of NO~x~ (37%) compared with the highest (29%). Notably, women giving birth during the first 4 years compared with the last 2 years of the study period dominated in the highest NO~x~ category.

*Gestational diabetes*. High parity, high BMI, age *≥* 35 years, type 1 diabetes, and chronic hypertension were more frequent features in women with gestational diabetes than the cohort as a whole ([Table 1](#t1){ref-type="table"}). Diabetic women were more likely than the cohort as a whole to have missing information on smoking (11% vs. 7%). A higher proportion of diabetic women came from the Middle East/North Africa, sub-Saharan Africa, and Asia than the cohort as a whole.

Crude and adjusted ORs for gestational diabetes increased monotonically with increasing NO~x~ exposure levels during the second trimester for second-, third-, and fourth-quartile crude ORs \[1.28 (95% CI: 1.07, 1.54); 1.84 (95% CI: 1.56, 2.18), and 1.98 (95% CI: 1.68, 2.35), respectively\], and for second-, third-, and fourth-quartile adjusted ORs \[1.19 (95% CI: 0.99--1.44); 1.52 (95% CI 1.28, 1.82); and 1.69 (95% CI: 1.41, 2.03), respectively\] ([Table 2](#t2){ref-type="table"}). Corresponding adjusted ORs from restricted analyses were 1.80 (95% CI: 1.49, 2.19) for mothers who did not move residence during pregnancy, 1.56 (95% CI: 1.24, 1.95) for Nordic-born mothers, and 1.53 (95% CI: 1.14, 2.05) for first-time mothers \[see Supplemental Material, Table S2 (http://dx.doi.org/10.1289/ehp.1205736)\]. ORs for NO~x~ exposure during the first trimester were similar to those for exposure during the second trimester (see Supplemental Material, Table S3).

###### 

ORs for gestational diabetes in relation to NO~x~ (µg/m^3^) and traffic density (vehicles/min).

  Exposure                                                                                                                                     Crude OR (95% CI)   Adjusted OR (95% CI)
  -------------------------------------------------------------------------------------------------------------------------------------------- ------------------- ----------------------
  NOx quartile                                                                                                                                                     
  Q1 = 2.5--8.9                                                                                                                                1.00 (reference)    1.00 (reference)
  Q2 = 9.0--14.1                                                                                                                               1.28 (1.07, 1.54)   1.19 (0.99, 1.44)
  Q3 = 14.2--22.6                                                                                                                              1.84 (1.56, 2.18)   1.52 (1.28, 1.82)
  Q4 = \> 22.7                                                                                                                                 1.98 (1.68, 2.35)   1.69 (1.41, 2.03)
  Traffic density within 200 m                                                                                                                                     
  No road                                                                                                                                      1.00 (reference)    1.00 (reference)
  \< 2                                                                                                                                         0.89 (0.75, 1.06)   0.93 (0.78, 1.12)
  2--5                                                                                                                                         1.04 (0.88, 1.23)   0.96 (0.81, 1.14)
  5--10                                                                                                                                        1.53 (1.27, 1.84)   1.18 (0.97, 1.43)
  \> 10                                                                                                                                        1.50 (1.24, 1.82)   1.23 (1.01, 1.51)
  Gestational diabetes model adjusted for parity, BMI, maternal age, calendar year, and country of origin and exposure for second trimester.                       

ORs for traffic density at the nearest road within 200 m suggested an association with residences in areas with \> 10 vehicles/min (adjusted OR = 1.23; 95% CI: 1.01, 1.51) compared with no road within 200 m ([Table 2](#t2){ref-type="table"}). The association was similar when restricted to nonmovers, but ORs were close to the null when the analysis was restricted to Nordic-born mothers and primiparae \[see Supplemental Material, Table S2 (http://dx.doi.org/10.1289/ehp.1205736)\].

Among Nordic-born women, the prevalence of gestational diabetes was higher among women living in an urban versus non-urban area (adjusted OR = 1.20; 95% CI: 0.99, 1.46). In addition, exposure to NO~x~ above the average value was positively associated with gestational diabetes among both urban (adjusted OR = 1.15; 95% CI: 0.98, 1.34 for second-trimester exposure \> 21.2 µg/m^3^) and non-urban mothers (adjusted OR = 1.37; 95% CI: 1.18, 1.60 for second-trimester exposure \> 8.9 µg/m^3^) \[see Supplemental Material, Table S4 (http://dx.doi.org/10.1289/ehp.1205736)\].

Estimated associations between gestational diabetes and the highest versus lowest quartile of second-trimester NO~x~ exposure among Nordic-born mothers (adjusted OR = 1.56; 95% CI: 1.24, 1.95) was comparable to the estimated effect of being *≥* 35 years of age (adjusted OR = 2.32; 95% CI: 1.89, 2.84 compared with age \< 25 years) and of being overweight (adjusted OR = 1.87; 95% CI: 1.55, 2.25 for BMI 25--29.9), but was weaker than the estimated effect of being obese (adjusted OR = 4.05; 95% CI: 3.34, 4.91 for BMI *≥* 30) \[see Supplemental Material, Table S5 (http://dx.doi.org/10.1289/ehp.1205736)\].

*Preeclampsia*. Women with preeclampsia were more likely to be primiparous, of Swedish origin, and obese (BMI *≥* 30) but less likely to be heavy smokers than the cohort as a whole ([Table 1](#t1){ref-type="table"}). Women with preeclampsia also were more likely to have missing information on BMI and smoking than the cohort as a whole.

Crude and adjusted ORs for preeclampsia increased with increasing quartiles of third-trimester NO~x~ exposures \[adjusted ORs for the second, third, and fourth quartiles of 1.28 (95% CI: 1.13, 1.46), 1.33 (95% CI: 1.17, 1.52), and 1.51 (95% CI: 1.32, 1.71, respectively\] ([Table 3](#t3){ref-type="table"}). Adjusted ORs for the highest versus lowest quartile from restricted analyses were 1.48 (95% CI: 1.27, 1.70) for mothers who did not move residence during pregnancy; 1.51 (95% CI: 1.31, 1.74) for Nordic-born mothers; and 1.61 (95% CI: 1.37, 1.90) for first-time mothers \[see Supplemental Material, Table S6 (http://dx.doi.org/10.1289/ehp.1205736)\].

###### 

ORs for preeclampsia in relation to NO~x~ (µg/m^3^) and traffic density (vehicles/min).

  Outcome/exposure                                                                                                                                    Crude OR (95% CI)   Adjusted OR (95% CI)
  --------------------------------------------------------------------------------------------------------------------------------------------------- ------------------- ----------------------
  Preeclampsia/NOx quartile                                                                                                                                               
  Q1 = 2.5--8.9                                                                                                                                       1.00 (reference)    1.00 (reference)
  Q2 = 9.0--14.1                                                                                                                                      1.21 (1.07, 1.38)   1.28 (1.13, 1.46)
  Q3 = 14.2--22.6                                                                                                                                     1.26 (1.11, 1.43)   1.33 (1.17, 1.52)
  Q4 = \> 22.7                                                                                                                                        1.34 (1.18, 1.52)   1.51 (1.32, 1.73)
  Preeclampsia mild/NOx quartile                                                                                                                                          
  Q1 = 2.5--8.9                                                                                                                                       1.00 (reference)    1.00 (reference)
  Q2 = 9.0--14.1                                                                                                                                      1.29 (1.12, 1.49)   1.38 (1.19, 1.60)
  Q3 = 14.2--22.6                                                                                                                                     1.32 (1.14, 1.52)   1.42 (1.23, 1.65)
  Q4 = \> 22.7                                                                                                                                        1.32 (1.14, 1.53)   1.51 (1.29, 1.77)
  Preeclampsia severe/NOx quartile                                                                                                                                        
  Q1 = 2.5--8.9                                                                                                                                       1.00 (reference)    1.00 (reference)
  Q2 = 9.0--14.1                                                                                                                                      0.97 (0.74, 1.26)   0.96 (0.72, 1.28)
  Q3 = 14.2--22.6                                                                                                                                     1.03 (0.79, 1.34)   0.99 (0.74, 1.32)
  Q4 = \> 22.7                                                                                                                                        1.42 (1.10, 1.83)   1.48 (1.12, 1.95)
  Preeclampsia/traffic density within 200 m                                                                                                                               
  No road                                                                                                                                             1.00 (reference)    1.00 (reference)
  \< 2                                                                                                                                                1.14 (1.00, 1.29)   1.12 (0.98, 1.28)
  2--5                                                                                                                                                1.09 (0.96, 1.24)   1.04 (0.91, 1.19)
  5--10                                                                                                                                               1.14 (0.98, 1.32)   1.14 (0.97, 1.34)
  \> 10                                                                                                                                               1.19 (1.02,1.40     1.10 (0.94,1.30)
  Preeclampsia mild/traffic density within 200 m                                                                                                                          
  No road                                                                                                                                             1.00 (reference)    1.00 (reference)
  \< 2                                                                                                                                                1.09 (0.95, 1.27)   1.06 (0.91, 1.23)
  2--5                                                                                                                                                1.06 (0.92, 1.23)   1.02 (0.88, 1.19)
  5--10                                                                                                                                               1.15 (0.97, 1.37)   1.13 (0.95, 1.36)
  \> 10                                                                                                                                               1.13 (0.95, 1.36)   1.04 (0.86, 1.26)
  Preeclampsia severe/traffic density within 200 m                                                                                                                        
  No road                                                                                                                                             1.00 (reference)    1.00 (reference)
  \< 2                                                                                                                                                1.27 (0.97, 1.66)   1.37 (1.03, 1.83)
  2--5                                                                                                                                                1.18 (0.90, 1.54)   1.13 (0.84, 1.53)
  5--10                                                                                                                                               0.99 (0.71, 1.40)   1.08 (0.75, 1.56)
  \> 10                                                                                                                                               1.27 (0.92, 1.77)   1.24 (0.86, 1.77)
  Preeclampsia models adjusted for gestational diabetes, type 1 diabetes, smoking, parity, BMI, country of origin, calendar year, and maternal age.                       

ORs for mild preeclampsia (*n* = 1,799) were similar to those for all cases, whereas severe preeclampsia was only associated with the highest quartile of exposure (adjusted OR = 1.48; 95% CI: 1.12, 1.95) ([Table 3](#t3){ref-type="table"}). ORs from models restricted to nonmovers, Nordic-born women, and first-time mothers were similar to those for all cases combined \[see Supplemental Material, Table S6 (http://dx.doi.org/10.1289/ehp.1205736)\].

Estimated associations for first- and second-trimester NO~x~ exposures were similar to ORs for third-trimester NO~x~ exposure for preeclampsia, mild preeclampsia, and severe preeclampsia \[see Supplemental Material, Table S7 (http://dx.doi.org/10.1289/ehp.1205736)\]. No clear associations between traffic density at the nearest road within 200 m and prevalence of preeclampsia were observed ([Table 3](#t3){ref-type="table"}; see also Supplemental Material, Table S6).

Among Nordic-born women, preeclampsia, mild preeclampsia, and severe preeclampsia all were significantly increased among urban versus non-urban women (e.g., adjusted OR for all preeclampsia = 1.40; 95% CI: 1.27, 1.54), but all three outcomes also were positively associated with NO~x~ exposure above average levels among women living in both urban and non-urban areas \[adjusted ORs for all preeclampsia of 1.27 (95% CI: 1.13, 1.44) and 1.37 (95% CI: 1.24, 1.51), respectively\] \[see Supplemental Material, Table S4 (http://dx.doi.org/10.1289/ehp.1205736)\].

Estimated associations of the highest versus lowest quartile of NO~x~ exposure with preeclampsia among Nordic-born women (e.g., adjusted OR for all preeclampsia = 1.51; 95% CI: 1.31, 1.74) were comparable to estimated effects of being \> 35 years of age (adjusted OR = 1.20; 95% CI: 1.03, 1.39), of having gestational diabetes (OR = 2.70; 95% CI: 1.76, 4.15), and of being overweight (OR = 1.85; 95% CI: 1.64, 2.09 for BMI 25--29.9), but less than the estimated effect of being obese (adjusted OR = 3.75; 95% CI: 3.28, 4.28 for BMI *≥* 30) \[see Supplemental Material, Table S5 (http://dx.doi.org/10.1289/ehp.1205736)\].

Discussion
==========

An increased prevalence of gestational diabetes with increasing air pollution exposure was observed in an area with annual average measurements (2004--2005) of around 20 µg/m^3^ at urban background sites and around 28 µg/m^3^ at traffic sites, which is well below current WHO air quality guidelines (NO~2~ annual average \< 40 µg/m^3^; [@r43]). Also, an association between air pollution exposure and preeclampsia was observed. The associations remained when we adjusted for confounders and performed analyses that were restricted to women who did not move during pregnancy, and women who were Nordic-born or first-time mothers. Positive associations with NO~x~ exposure were evident in both urban and rural settings. For gestational diabetes and all cases of preeclampsia combined, associations increased monotonically with each quartile of NO~x~. Mild preeclampsia was significantly associated with all exposures above the first quartile, whereas severe preeclampsia was associated with the highest quartile of exposure only.

*Strengths and weaknesses*. The main strength of the present study is the large dataset from the Swedish Medical Birth Registry, comprising routinely assembled information from antenatal health care clinics covering almost all pregnancies in the region. Thus, the risk of selection bias was minimized, and well-known risk factors could be taken into account. Notably, almost all pregnant women were screened for glucose intolerance, and strict criteria were applied for the diagnosis of gestational diabetes and preeclampsia. Although effect estimates generally decreased after adjustment for covariates, the magnitude of changes was modest. As in all observational studies, there is a potential for bias due to confounding by unmeasured risk factors. However, risk factors such as family history of type 2 diabetes, polycystic ovary syndromes, and low own birth weight are not likely to act as confounders because they are not likely to be associated with the exposure. Another limitation is missing data, especially for BMI and smoking, which could be a potential source of bias.

A limitation was the lack of individual-level information on socioeconomic status, which could be associated with the outcomes and with the exposures. To address this, we performed separate analyses limited to Nordic-born women to achieve a more homogenous study group, because previous studies in Scania have reported associations between country of origin, air pollution, and socioeconomic status in the study area ([@r8]; [@r18]; [@r32]). Previous studies using Swedish Medical Birth Registry data have reported that associations between maternal education (a proxy measure of socioeconomic status) and outcomes such as low birth weight and preterm birth could be explained almost entirely by a higher prevalence of smoking among women with lower levels of education ([@r10]). Thus, we believe that unmeasured confounding by factors related to socioeconomic status was unlikely to have caused the associations observed.

One strength of the study is the individually modeled NO~x~ exposure estimates. Modeled and measured outdoor data show a good correspondence ([@r33]). A spatial resolution of 500 × 500 m is appropriately accurate for aggregated monthly means in this study area ([@r31]). The resolution should accordingly be reasonable for trimester means as well, because temporal aggregation allowed lower spatial resolution. Road traffic data have higher spatial resolution, but traffic density can be misclassified because traffic density measurements are not always performed on a yearly basis. We classified traffic exposure based on roads with the highest traffic density within a 200-m radius only. Regardless, the chosen proxies do not reflect the true individual exposure because a large proportion of traffic exposure, particularly for adults, takes place during commuting and at the workplace ([@r23]).

An inherent problem is that the NO~x~ and traffic exposure categories were strongly correlated with urban/non-urban contrasts. In the subcohort of Nordic-born women, there was an urban/rural contrast with higher prevalence of exposure in the two main cities. However, contrasts within urban as well as non-urban areas were also observed, with higher prevalence with higher exposure to NO~x~. Proposing that the results obtained in this study reach beyond urban/nonurban contrasts would consequently suggest a true association between air pollution and gestational diabetes and preeclampsia.

*Previous studies*. To our knowledge, only a few research groups have investigated possible associations between gestational complications and air pollution ([@r14]; [@r24]; [@r38], [@r37]; [@r39]; [@r45], [@r46]). [@r14] reported positive associations between preeclampsia and model-based estimates of first-trimester PM~2.5~ and O~3~, but not PM~10~, in a cohort of \> 34,000 births, whereas [@r39] reported associations between gestational hypertension (including preeclampsia) and PM~2.5~ and PM~10~ in a study of \> 200,000 births. [@r45] reported positive associations between preeclampsia and NO~x~ and PM~2.5~. [@r46] found an association between preeclampsia and a variety of measures of air pollution exposure (measured as CO, NO, NO~2~, NO~x~, and PM~2.5~) regardless of the exposure assessment method employed; however, estimated effect depended on temporal and spatial variation in the models. [@r24] reported no associations between exposure and preeclampsia, but the study was relatively small. [@r38] did not find an association with traffic density and gestational complications, but in a latter study ([@r37]) they found an association between gestational hypertension and exposure to NO~2~ and PM~10~. On the relationship between exposure and preeclampsia, however, their results were inconclusive.

*Plausibility and comments, from a medical point of view*. The biological plausibility of air pollution (specifically fine particulate matter) affecting health has been discussed by [@r20], focusing on exposure effects on blood pressure ([@r5]) and the cardiovascular system ([@r5]), aspects of substantial relevance to health during pregnancy ([@r47]). The hypothesized biological pathways comprise systemic inflammation and placental oxidative stress ([@r22]; [@r26]; [@r34]). Previous studies have shown a decreased risk of preeclampsia in relation to tobacco smoking ([@r26]). However, a possible explanation could be that air pollution from traffic and tobacco smoking do have some chemical components in common, whereas other components differ.

To put the findings of our study into perspective, the estimated effects of air pollution on pregnancy should be compared with the estimated effects of well-known risk factors. Among women born in Nordic countries, the association between the highest versus lowest quartile of NO~x~ exposure and gestational diabetes was comparable to the estimated effect of being overweight, but weaker than the estimated effect of being obese. Similarly, the association between high NO~x~ exposure and preeclampsia was similar to the estimated effects of having gestational diabetes, being overweight, or being \> 35 years of age.

Gestational complications, such as gestational diabetes and preeclampsia, have implications not only for fetal morbidity and mortality, but also for maternal health. It has been estimated that one of three women with gestational diabetes will eventually develop type 2 diabetes ([@r16]). If the association between air pollution and pregnancy complications represents a causal relation, it would have profound implications for public health, particularly in countries with limited maternal health care.

Conclusion
==========

Statistically significant associations between NO~x~ exposure and gestational diabetes and preeclampsia were observed in a population exposed to air pollution at levels below current air quality guidelines.

Supplemental Material
=====================
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Click here for additional data file.
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